Supplementary Table S2 from Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1–Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study
Authors:
- Kohei ShitaraKSKohei Shitara
- Motohiro TamiyaMTMotohiro Tamiya
- Kyoichi OkishioKOKyoichi Okishio
- Hisashi HosakaHHHisashi Hosaka
- Katsunori ShinozakiKSKatsunori Shinozaki
- Nobuhiko SekiNobuhiko Seki
- Hiroki HaraHHHiroki Hara
- Yukiya NaritaYNYukiya Narita
- Takeshi ShiraishiTSTakeshi Shiraishi
- Yosuke TamuraYTYosuke Tamura
- Akihito TsujiATAkihito Tsuji
- Kunihiro TsujiKTKunihiro Tsuji
Open Access
- 15 October 2025
- other
- Published by American Association for Cancer Research (AACR)